vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Essex Property Trust (ESS). Click either name above to swap in a different company.
Essex Property Trust is the larger business by last-quarter revenue ($479.6M vs $270.4M, roughly 1.8× Enhabit, Inc.). Essex Property Trust runs the higher net margin — 17.9% vs -14.3%, a 32.2% gap on every dollar of revenue. On growth, Essex Property Trust posted the faster year-over-year revenue change (5.5% vs 4.7%). Over the past eight quarters, Essex Property Trust's revenue compounded faster (6.0% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Essex Property Trust is a publicly traded real estate investment trust that invests in apartments in California and in the Seattle metropolitan area.
EHAB vs ESS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $479.6M |
| Net Profit | $-38.7M | $85.7M |
| Gross Margin | — | 70.0% |
| Operating Margin | -12.3% | 31.7% |
| Net Margin | -14.3% | 17.9% |
| Revenue YoY | 4.7% | 5.5% |
| Net Profit YoY | 15.9% | -71.6% |
| EPS (diluted) | $-0.76 | $1.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $479.6M | ||
| Q3 25 | $263.6M | $473.3M | ||
| Q2 25 | $266.1M | $469.8M | ||
| Q1 25 | $259.9M | $464.6M | ||
| Q4 24 | $258.2M | $454.5M | ||
| Q3 24 | $253.6M | $450.7M | ||
| Q2 24 | $260.6M | $442.4M | ||
| Q1 24 | $262.4M | $426.9M |
| Q4 25 | $-38.7M | $85.7M | ||
| Q3 25 | $11.1M | $172.7M | ||
| Q2 25 | $5.2M | $231.5M | ||
| Q1 25 | $17.8M | $212.8M | ||
| Q4 24 | $-46.0M | $301.7M | ||
| Q3 24 | $-110.2M | $125.5M | ||
| Q2 24 | $-200.0K | $99.0M | ||
| Q1 24 | $200.0K | $285.1M |
| Q4 25 | — | 70.0% | ||
| Q3 25 | — | 69.2% | ||
| Q2 25 | — | 70.7% | ||
| Q1 25 | — | 69.6% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.5% | ||
| Q2 24 | — | 70.8% | ||
| Q1 24 | — | 69.7% |
| Q4 25 | -12.3% | 31.7% | ||
| Q3 25 | 6.4% | 44.5% | ||
| Q2 25 | 6.3% | 59.5% | ||
| Q1 25 | 6.1% | 55.3% | ||
| Q4 24 | -16.0% | 67.0% | ||
| Q3 24 | -38.6% | 28.6% | ||
| Q2 24 | 4.3% | 31.1% | ||
| Q1 24 | 4.9% | 31.0% |
| Q4 25 | -14.3% | 17.9% | ||
| Q3 25 | 4.2% | 36.5% | ||
| Q2 25 | 2.0% | 49.3% | ||
| Q1 25 | 6.8% | 45.8% | ||
| Q4 24 | -17.8% | 66.4% | ||
| Q3 24 | -43.5% | 27.8% | ||
| Q2 24 | -0.1% | 22.4% | ||
| Q1 24 | 0.1% | 66.8% |
| Q4 25 | $-0.76 | $1.24 | ||
| Q3 25 | $0.22 | $2.56 | ||
| Q2 25 | $0.10 | $3.44 | ||
| Q1 25 | $0.35 | $3.16 | ||
| Q4 24 | $-0.92 | $4.00 | ||
| Q3 24 | $-2.20 | $1.84 | ||
| Q2 24 | $0.00 | $1.45 | ||
| Q1 24 | $0.01 | $4.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $76.2M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $5.5B |
| Total Assets | $1.2B | $13.2B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $76.2M | ||
| Q3 25 | $56.9M | $66.0M | ||
| Q2 25 | $37.1M | $58.7M | ||
| Q1 25 | $39.5M | $98.7M | ||
| Q4 24 | $28.4M | $66.8M | ||
| Q3 24 | $45.7M | $71.3M | ||
| Q2 24 | $28.5M | $55.2M | ||
| Q1 24 | $36.5M | $499.0M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | $6.4B | ||
| Q2 25 | $456.9M | $6.4B | ||
| Q1 25 | $467.3M | $6.8B | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | $6.4B | ||
| Q2 24 | $512.7M | $6.2B | ||
| Q1 24 | $526.7M | $6.6B |
| Q4 25 | $534.0M | $5.5B | ||
| Q3 25 | $566.8M | $5.6B | ||
| Q2 25 | $552.4M | $5.6B | ||
| Q1 25 | $543.2M | $5.6B | ||
| Q4 24 | $523.5M | $5.5B | ||
| Q3 24 | $566.1M | $5.4B | ||
| Q2 24 | $674.3M | $5.5B | ||
| Q1 24 | $672.3M | $5.5B |
| Q4 25 | $1.2B | $13.2B | ||
| Q3 25 | $1.2B | $13.2B | ||
| Q2 25 | $1.2B | $13.2B | ||
| Q1 25 | $1.2B | $13.2B | ||
| Q4 24 | $1.2B | $12.9B | ||
| Q3 24 | $1.3B | $12.6B | ||
| Q2 24 | $1.4B | $12.5B | ||
| Q1 24 | $1.4B | $12.9B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | 1.15× | ||
| Q2 25 | 0.83× | 1.14× | ||
| Q1 25 | 0.86× | 1.22× | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | 1.18× | ||
| Q2 24 | 0.76× | 1.13× | ||
| Q1 24 | 0.78× | 1.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $1.1B |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | 12.53× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $1.1B | ||
| Q3 25 | $37.8M | $342.6M | ||
| Q2 25 | $10.6M | $216.1M | ||
| Q1 25 | $17.9M | $281.5M | ||
| Q4 24 | $-4.1M | $1.1B | ||
| Q3 24 | $28.4M | $316.2M | ||
| Q2 24 | $9.6M | $218.9M | ||
| Q1 24 | $17.3M | $314.9M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $36.2M | — | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $17.6M | — | ||
| Q4 24 | $-4.7M | — | ||
| Q3 24 | $27.7M | — | ||
| Q2 24 | $8.9M | — | ||
| Q1 24 | $15.5M | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | -1.8% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 5.9% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | 12.53× | ||
| Q3 25 | 3.41× | 1.98× | ||
| Q2 25 | 2.04× | 0.93× | ||
| Q1 25 | 1.01× | 1.32× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | — | 2.52× | ||
| Q2 24 | — | 2.21× | ||
| Q1 24 | 86.50× | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
ESS
Segment breakdown not available.
